If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBioventix Regulatory News (BVXP)

Share Price Information for Bioventix (BVXP)

Share Price is delayed by 15 minutes
Get Live Data
1,600.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 100.00 (6.452%)
Market Cap: £83.60m
BVXP Live PriceLast checked at - London Stock Exchange

Intraday Bioventix Share Chart

Holding(s) in Company

10 Apr 2017 11:18

Bioventix Plc - Holding(s) in Company

Bioventix Plc - Holding(s) in Company

PR Newswire

London, April 10

For filings with the FCA include the annex
For filings with issuer exclude the annex
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: iiBIOVENTIX PLC
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments
An event changing the breakdown of voting rightsX
Other (please specify):
3. Full name of person(s) subject to the notification obligation: iiiMITON GROUP PLC
4. Full name of shareholder(s) (if different from 3.):iv
5. Date of the transaction and date on which the threshold is crossed or reached: v05/04/2017
6. Date on which issuer notified:06/04/2017
7. Threshold(s) that is/are crossed or reached: vi, vii13%

8. Notified details:
A: Voting rights attached to shares viii, ix
Class/type of shares if possible using the ISIN CODESituation previous to the triggering transactionResulting situation after the triggering transaction
Number of SharesNumber of Voting RightsNumber of sharesNumber of voting rights% of voting rights x
DirectDirect xiIndirect xiiDirectIndirect
GB00B4QVDF07664,296664,296664,296664,29612.93%
B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial instrumentExpiration date xiiiExercise/ Conversion Period xivNumber of voting rights that may be acquired if the instrument is exercised/ converted.% of voting rights
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi
Resulting situation after the triggering transaction
Type of financial instrumentExercise priceExpiration date xviiExercise/ Conversion period xviiiNumber of voting rights instrument refers to% of voting rights xix, xx
NominalDelta
Total (A+B+C)
Number of voting rightsPercentage of voting rights
664,29612.93%

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: xxi
CF MITON UK MULTI CAP INCOME FUND 336,367
DIVERSE INCOME TRUST 232,929
CF MITON UK SMALLER COMPANIES FUND 95,000
Proxy Voting:
10. Name of the proxy holder:
11. Number of voting rights proxy holder will cease to hold:
12. Date on which proxy holder will cease to hold voting rights:
13. Additional information:
14. Contact name:GEORGE LATIMER-BUTLER
15. Contact telephone number:0203 714 1486
Date   Source Headline
24th Jun 20264:10 pmRNSDirector Dealing
18th May 20268:45 amRNSHolding(s) in Company
28th Apr 20263:45 pmRNSDirector Dealing
20th Apr 202611:54 amRNSShare Options Awarded
13th Apr 20267:00 amRNSDirector Dealing
8th Apr 20264:20 pmRNSDirector Dealing
30th Mar 20267:00 amRNSInterim Results
24th Feb 20267:00 amRNSAppointment of Non-Executive Director
4th Dec 20253:59 pmRNSResult of AGM
26th Nov 20258:50 amRNSDirector Dealing
11th Nov 20257:00 amRNSPosting of Annual Report and Notice of AGM
4th Nov 20254:12 pmRNSDirector Dealing
30th Oct 20257:00 amRNSDirector Dealing
27th Oct 20253:53 pmRNSDirector Dealing
27th Oct 20257:00 amRNSResults for the year ended 30 June 2025
13th Aug 20252:19 pmRNSHolding(s) in Company
28th Apr 20255:13 pmRNSDirector Dealing
11th Apr 20257:00 amRNSExercise of Options and Issue of Equity
31st Mar 20257:00 amRNSInterim Results
24th Dec 20249:14 amRNSDirector Dealing
6th Dec 20247:00 amRNSResult of AGM
4th Dec 20243:34 pmRNSHolding(s) in Company
22nd Nov 20243:56 pmRNSDirector/PDMR Shareholding
8th Nov 20247:57 amRNSNotice of AGM
31st Oct 20247:00 amRNSDirector/PDMR Shareholding
28th Oct 20247:00 amRNSResults for the year ended 30 June 2024
25th Oct 202410:37 amRNSHolding(s) in Company
16th Oct 20241:51 pmRNSHolding(s) in Company
30th Apr 20247:00 amRNSDirector/PDMR Shareholding
12th Apr 202411:05 amRNSHolding(s) in Company
25th Mar 20247:00 amRNSInterim Results
29th Jan 20243:15 pmRNSDirector/PDMR Shareholding
7th Dec 20233:26 pmRNSResult of AGM
28th Nov 20233:26 pmRNSDirector/PDMR Shareholding
16th Nov 202312:40 pmRNSHolding(s) in Company
10th Nov 20234:23 pmRNSPosting of Annual Report and Notice of AGM
7th Nov 202312:07 pmRNSHolding(s) in Company
1st Nov 20234:07 pmRNSHolding(s) in Company
30th Oct 20237:00 amRNSResults for the year ended 30 June 2023
25th Sep 20234:28 pmRNSHolding(s) in Company
19th Sep 20232:29 pmRNSHolding(s) in Company
24th Jul 20237:00 amRNSHolding(s) in Company
6th Jul 20232:48 pmRNSHolding(s) in Company
30th May 20237:00 amRNSBoard Appointment
19th May 20237:00 amRNSDirector/PDMR Shareholdings and Issue of Equity
25th Apr 202310:35 amRNSDirector/PDMR Shareholding
11th Apr 20232:45 pmRNSHolding(s) in Company
31st Mar 20232:45 pmRNSDirector/PDMR Shareholding
27th Mar 20237:00 amRNSInterim Statement
8th Mar 20235:50 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.